Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Blood-Based Molecular Clock Biomarkers in Predicting the Onset Time of Acute Ischemic Stroke: A Prospective Observational Study

NCT07453277 is registered in ClinicalTrials.gov with Izmir Katip Celebi University as lead sponsor.

NCT NCT07453277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07453277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Blood-Based Molecular Clock Biomarkers in Predicting the Onset Time of Acute Ischemic Stroke: A Prospective Observational Study
Lead sponsor
Izmir Katip Celebi University
Phase
Observational
Overall status
Active, not recruiting
Start date
March 1, 2026
Completion date
April 1, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

emergency medicine, stroke acute